Question 1

Who owns GDTC?

Accepted Answer

CYTOMED THERAPEUTICS LIMITED (GDTC) is held by 3 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is XTX Topco Ltd as of Q1 2026.

Question 2

Are institutions buying or selling GDTC?

Accepted Answer

In Q1 2026, 2 institutions opened or increased positions in CYTOMED THERAPEUTICS LIMITED while 1 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on GDTC?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for CYTOMED THERAPEUTICS LIMITED.

Question 4

How many hedge funds hold GDTC?

Accepted Answer

3 institutional investors report holding CYTOMED THERAPEUTICS LIMITED (GDTC) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into GDTC?

Accepted Answer

As of Q1 2026, tracked institutions in CYTOMED THERAPEUTICS LIMITED show 2 buyers versus 1 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
XTX Topco Ltd	New	10,136	$10,136	0.0%	-1.90%	24
UBS Group AG	Increased	6,182(+480.5%)	$6,182	0.0%	-22.98%	17
OSAIC HOLDINGS, INC.	Unchanged	21	$21	0.0%	-26.95%	0
SUSQUEHANNA INTERNATIONAL GROUP, LLP	Exited	0(-100.0%)	$39,673	0.0%	-25.53%	0

CYTOMED THERAPEUTICS LIMITED

Continue exploring

Other Healthcare stocks held by institutions